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Abstract
Effects of Induced Acute Phase Response in Ewes on Early Embryo Survival

Tina Lynn Dow
Early pregnant ewes, 5/6 day post coitus (dpc) were used as a model to study
early embryonic loss via gram-positive bacterial infections, such as mastitis. Ewes 5/6
dpc were injected with a gram-positive bacteria cell wall component, peptidoglycanpolysaccharide (PG-PS), to induce an innate immune system acute phase response
(APR). The induction of the APR and its reactant molecules, such as cytokines and acute
phase proteins (APP), were initiated to study their effects on embryonic loss. Twenty
Suffolk ewes were synchronized for estrus and bred by fertile rams. At 4 dpc ewes were
anesthetized and catheters were surgically placed in the right rear leg in the caudal vena
cava via saphenous vein, as well as in the jugular. Ewes were randomly assigned to
treatment groups on 5 dpc, and received either a 60 µg/kg BW dose of PG-PS (n=10) or a
sham injection of 0.9% NaCl (n=10) i.v. in the jugular vein contralateral of the catheter.
Plasma was collected from jugular and caudal vena cava via the saphenous vein before
challenge, followed by post challenge samples every 15 minutes until 2 hours, every hour
until 12 hours, and once at 24, 36, and 48 hours. Assays were conducted for APR
reactants tumor necrosis factor-α (TNF-α), serum amyloid A (SAA), and haptoglobin
(Hp), as well as the pregnancy maintenance hormone, progesterone (P4). In addition,
behavior changes and body temperature were also documented before PG-PS injection
followed by every hour for 12 hours and then again at 24, 36, and 48 post challenge.
Concentrations of TNF-α and P4 were quantified using radioimmunoassay, whereas
ELISA was used to measure SAA and HP concentrations. Intoxication of day 5/6
pregnant ewes with 60 µg/kg BW PG-PS induced significant differences in TNF-α
concentration between sample sites (p<0.001) and treatment groups (p<0.02). SAA and
Hp concentrations increased significantly (p<0.0001) in challenged ewes. Fever, loss of
appetite, lethargy, and vaginal discharge were documented in all treated ewes, as well as
100 % embryonic loss by 21 dpc. Data from this experiment demonstrate that injection
of PG-PS systemically leads to production of APP and behavioral changes characteristic
of an APR.
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Introduction
The embryo’s ability to biochemically communicate with the uterus is crucial for
continuation of pregnancy. A viable conceptus must signal to maintain the life of the
corpus luteum (CL), and, immunologically speaking, prevent the mother from rejecting
the semi-allogenic fetus. The mechanism, termed maternal recognition of pregnancy,
involves structural, hormonal and genetic changes in both the mother and embryo (Paria
et al., 2001). Overall, these changes ensure that progesterone (P4), the hormone secreted
by the CL that maintains pregnancy, is continually produced, as a result the preimplanted embryo is nourished, and the uterus becomes prepared for the conceptus to
implant, which causes the start of placentation followed by the placental production of P4
(Senger, 2003).
For a variety of domestic mammals, receptivity to a male, ovulation and
fertilization are proficient processes. However, early embryonic losses are relatively
high; losses in swine have been estimated to be ~25-30% (Moore et al., 2005), whereas
humans experience ~35% loss (Wang et al., 2003), and cattle and sheep lose up to 3035% (Hansen and Soto, 2004). Shahani and colleagues (1992) observed that in the
mouse ~75% of embryonic loss takes place within the first six days of gestation. In
addition to bringing death to the embryo, early embryonic loss has negative effects on the
dam, as well as a significant economic impact on animal agriculture (Lucy et al., 2004;
Moore et al., 2005). Estimates suggest that a reduction in embryonic loss by just 2.8%
would result in the additional production of 135 thousand sheep, 1 million beef cattle, 3.2
million pigs, and 3.5 million gallons of milk per year (Senger, 2003). Many factors
interact to cause early embryonic loss, in addition to genetic abnormalities of the
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conceptus that restrict growth and development. In sheep, cattle and pigs, embryos
undergo a period of growth wherein they change from a spherical form to one which is
more tubular and then filamentous prior to implantation. During this time, day 13-21 of
gestation, the embryo begins to produce a cytokine, interferon-tau (IFN-τ), the signal for
maternal recognition of pregnancy (Spencer et al., 2004). Embryos that are
developmentally delayed are unable to produce IFN-τ at the correct time or in appropriate
concentrations. Moreover, the lack of the maternal signal results in endometrial
production of prostaglandin F2α (PGF2α) and ultimately luteolysis.
External environmental factors including nutrition, weather, and disease also
affect early embryonic loss. Reproductive efficiency is impacted by stressors such as
heat or cold extremes, poor diet, as well as pathogenic living conditions (Hansen, 2007).
Research involving heat stressors on embryonic survival in sheep carried out by Dutt in
1963 demonstrated the conceptus was extremely vulnerable to detrimental effects
initiated by a significant increase in maternal body temperature between days 0 and 4 of
gestation. However, from approximately day 6 of gestation, an embryonic heat tolerance
developed allowing the embryo to be less susceptible to inflammatory factors such as
cytokines, as well as other hypothalamic-pituitary-adrenal and hypothalamic-pituitaryovarian disturbances that could result in a decline in embryonic survival.
Bacterial infections have detrimental effects on the survival of the developing
conceptus. For example, mastitis, an inflammatory disease of the mammary gland,
disrupts reproduction in dairy cattle. Barker and colleagues in 1998 observed a decrease
in conception rate if mastitis occurred before the first insemination, and that more
inseminations were required to establish pregnancy if cows were infected with mastitis
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after first insemination. Either situation resulted in a longer interval between calving and
pregnancy. Furthermore, mated ewes inoculated with either peptidoglycanpolysaccharide, a gram-positive bacterial cell wall component, or killed Streptococcus
pyogenes to mimic the effects of mastitis increased early embryonic loss (Stewart et al.,
2003; Holásková et al., 2004). Therefore, the early immune response, i.e., inflammation,
associated with diseases such as bacterial derived mastitis likely compromise embryonic
survival (Soto et al., 2003; Hansen et al., 2004).
Reproduction Cycle
Reproduction is manifested as a cycle of events that begin when the female is
sexually receptive (termed estrus in non-primate mammals) and continues through
pregnancy and parturition, at which time the series is repeated. The interval from one
estrus to another is designated as an estrous cycle, and its length is determined by
endocrine interactions within the hypothalamo-pituitary-ovarian axis, as influenced by
uterine secretions in most species. Although the hypothalmo-pituitary-ovarian axis
controls ovulation via stimulation of localized hormonal secretions in the reproductive
tract, for sheep and cattle the estrous cycle is uterine-dependent (Land et al., 1976). In
work reviewed by Bazer in 1998, hysterectomy during the estrous cycle in both cattle and
sheep resulted in the lifespan of the CL being extended. Therefore, the uterus is the
source of PGF2α, the luteolysin. Because hysterectomy did not result in an extended
lifespan of the CL in primates, the menstrual cycle is uterine-independent (Bazer, 1998).
Estrous Cycle in the Ewe
Ewes are seasonally polyestrous with lengths of estrous cycles averaging 17 days.
Because their estrous cycles begin in the late summer or early fall and continue through
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early spring, ewes are classified as short day breeders. Seasonal breeding patterns are
vital for neonatal survival, as ewes conceive in the late fall to early winter and lamb in the
early spring when weather conditions are more optimal and food is readily available.
Gonadatropin-releasing hormone (GnRH), a decapeptide secreted by the
hypothalamus in a pulsatile fashion, stimulates the release of two glycoprotein hormones,
follicle stimulating hormone (FSH) and lutinizing hormone (LH), from the anterior
pituitary gland. Each enters the systemic circulation and travels to its target site on the
ovary prompting follicular development, ovulation, and formation of the CL. Because
FSH and LH exert distinct effects on the ovary, the estrous cycle can be divided into two
phases, the follicular phase and the luteal phase (Senger, 2003).
Follicular Phase
The follicular phase of the estrous cycle is named because the principal structure
and hormonal target on the ovary at this time is the follicle(s). The follicular phase
consists of two periods: proestrus and estrus. Proestrus begins after the CL from the
previous estrous cycle has regressed. The second part of the follicular phase is
characterized by estrus and ovulation.
During the follicular phase, follicular growth is accompanied by secretion of
estradiol (E2) by the follicles. An increase in systemic concentrations of E2 brings about
female receptivity to the male, uterine gland growth and increased mucus secretions in
the cervix and vagina. E2 has a positive feedback upon the hypothalamic preovulatory
surge center to stimulate secretion of GnRH that is both high in frequency and amplitude.
The surge in GnRH secretion subsequently stimulates a surge in LH from the anterior
pituitary that results in ovulation (Baird and McNeilly, 1981).
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Ovulation is the end result of collaboratory effects of increases in follicular
vascularization, smooth muscle contractions via prostaglandin synthesis, and collagenase
activity on the follicular wall (Krishna et al., 1986; Murdoch et al., 1986). For the ovid,
estrus can last 18-48 hours, with ovulation beginning at about 24-30 hours. The ovulated
follicle undergoes both cellular and structural changes to form the CL, which is the main
ovarian structure in the luteal phase.
Luteal Phase
The luteal phase which constitutes 80 % of the estrous cycle, beginning after
ovulation and continues until the CL regresses in the absence of pregnancy, is subdivided
into two parts: metestrus and diestrus. Due to the rupture of small blood vessels during
ovulation, blood clots are formed in the ovulating follicle which is then termed a corpus
hemorrhagicum (CH), a transition structure leading to the formation of the CL, an
endocrine gland (Bazer, 1998). After ovulation, cells from the theca interna and the
granulosa form small (theca) and large (granulosa) luteal cells (Hoyer and Niswender,
1985). Complete lutenization occurs at metestrus, which in sheep lasts approximately 45 days and is characterized by low systemic concentrations of E2 as well as P4. At day 10
to 14, the CL reaches its maximum size and function. If an embryo is not present P4
concentrations will decrease with the regression of the CL (Senger, 2003).
Depending on the presence or absence of a conceptus, P4 will act upon multiple
reaction sites within the hypothalamo-pituitary-ovarian axis, along with uterine and
mammary targets (Chappell et al., 1997; Scott et al., 2000; Meikle et al., 2004). In the
hypothalamus, P4 inhibits GnRH secretion and suppresses secretion of FSH and LH from
the pituitary. As E2 concentrations are low, behaviors associated with high E2, such as
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estrus, are suppressed as well. In addition, P4 directly affects physiological changes of
the uterine endometrium to provide an optimal environment for a developing embryo
(Bazer and First, 1983; Spencer, 2002). P4 stimulates the production of secretory
proteins, which, in turn, aid in the differentiation and glandular remodeling of the uterine
tissue, directly causing the production of histotroph (Roberts and Bazer, 1988). In most
domestic livestock species ovulation is spontaneous and regression of the CL is a uterinedependent process. As McCracken and colleagues in 1972 observed, the uterine
endometrium is the main source for PGF2α, which is transported to the ovary via a
counter current exchange mechanism of the uterine vein and ovarian artery. At the ovary,
PGF2α exerts its effects on the CL and stimulates regression of the CL and a decrease in
P4 concentrations. Additionally, the CL itself also secretes PGF2α.
Luteolysis is characterized as both a change in function and structure of the CL.
As the CL regresses plasma concentrations of P4 fall almost immediately, resulting in
luteal cell death (Hoyer, 1998). Working with ewes, McGuire et al. (1994) showed that
administering PGF2α would result in decreased concentrations of systemic P4 within 5
hours, with luteal cell death following after ~12 hours. The regression of the CL is the
keystone event that characterizes the end of the luteal phase. However, if there is a viable
conceptus, the lifespan of the CL will be prolonged. The conceptus will produce antiluteolytic signals that inhibit the production of PGF2α as well as alert the female that it is
in the reproductive tract and that it should be under immune system protection; the
process is referred to as the maternal recognition of pregnancy (Bazer, 1998).
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Early Pregnancy
Upon copulation and intromission, the male deposits an ejaculate rich with
uncapacitated sperm and seminal plasma. The volume of the ejaculate and the site of
deposition is species specific. Once in the female reproductive tract, the semen is
immediately moved via uterine contractions and watery mucous secretions upward into
the cervix, passing through the uterine horn eventually reaching the ampula/isthmus
junction, the site of fertilization, in the oviduct. Simultaneously, the sperm goes through
a maturation process termed capacitation in which enzymes in the female tract act to
remove adherent seminal plasma proteins, as well as works to reorganize sperm plasma
membrane lipids and proteins (Senger, 2003). In addition, influxes of extracellular
calcium, increase in cyclic AMP, and a decrease in intracellular pH promote
hyperactivity of the sperm. This period of increased motility of the sperm both aids in
propelling the sperm to the egg and in driving it through the outermost egg coat, the zona
pellucida (Dean, 1992).
The binding of sperm to the zona pellucida, is a receptor-ligand interaction with a
high degree of specificity. Glycoproteins on the zona pellucida function as sperm
receptors. Almeida et al., (1995) observed that there are several proteins on the surface of
the sperm that bind to the zona pellucida carbohydrate receptors. The constant propulsive
force from the sperm’s flagellating tail, in combination with acrosomal enzymes, allows
the sperm to create a tract through the zona pellucida. These two factors, motility- and
zona-digesting enzymes, allow the sperm to traverse the zona pellucida. Some
investigators believe that sperm motility is of overriding importance to zona penetration,
allowing the knife-shaped mammalian sperm to basically cut its way through the zona
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pellucida at the same time acrosomal enzymes are digesting the zona (Allen and Green,
1997). Once a sperm penetrates the zona pellucida, it binds to and fuses with the plasma
membrane of the oocyte at the posterior (post-acrosomal) region of the sperm head
(Denker, 2000).
Prior to fertilization, the egg is quiescent, arrested in metaphase of the second
meiotic division. Upon binding of a sperm, the egg rapidly undergoes a number of
metabolic and physical changes that collectively are called egg activation. Prominent
effects include a rise in the intracellular concentration of calcium, completion of the
second meiotic division and the cortical reaction, massive exocytosis of cortical granules
seen shortly after sperm-oocyte fusion. Cortical granules contain a mixture of enzymes,
including several proteases, which diffuse into the zona pellucida and alter its structure,
inducing what is known as the zona reaction. Components of cortical granules may also
interact with the oocyte plasma membrane (Wasserman, 1990; Yanagimachi, 1996).
As Denker (2000) reported, the critical importance of the zona reaction is that it
represents the major block to polyspermy in most mammals. Polyspermy is the entrance
into the egg by more than one sperm resulting in a nonviable zygote. This block is the
result of two measurable changes induced in the zona pellucida: the zona pellucida
hardens, and the sperm receptors in the zona pellucida are destroyed (Dunbar, 1991). The
loss of sperm receptors can be demonstrated by mixing sperm with both unfertilized
oocytes (which have not yet undergone the zona reaction) and two-cell embryos (which
have previously undergone cortical and zona reactions). Whereby, sperm attach avidly to
the zona pellucida of oocytes, but fail to bind to the two-cell embryos (Glabe and
Vacquier, 1978).
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Following fusion of the fertilizing sperm with the oocyte, the sperm head is
incorporated into the egg cytoplasm. The nuclear envelope of the sperm disperses, and
the chromatin rapidly loosens from its tightly packed state in a process called
decondensation. In vertebrates, other sperm components, including mitochondria, are
degraded rather than incorporated into the embryo. Chromatin from both the sperm and
egg are soon encapsulated in a nuclear membrane, forming pronuclei. Each pronucleus
contains a haploid genome until their membranes break down, and the two genomes
condense into chromosomes, thereby reconstituting a diploid organism (Gilbert, 2006).
Embryogenesis
Once fertilization is accomplished, the resulting structure is called the zygote.
The zygote undergoes rapid cell division with no significant growth (cleavage) and is
initiated approximately 24-30 hours after fertilization (Wong and Adashi, 2006). The
dividing cells of the zygote are called blastomeres and become smaller in size with each
successful cell division as the size is constrained by the presence of the zona pellucida. It
is important to note that it is the maternal mRNA that controls the first cleavage
divisions, with the embryonic genome becoming activated at the 2-cell stage in the mouse
and golden hamster (Seshagiri et al., 1992), the 4- to 8- cell stage in the human (Hardy
and Spanos, 2002), and the 8-cell stage in swine, cattle and sheep (Crosby et al., 1988).
When the embryo has reached the 16-cell stage, the blastomeres become more tightly
compact forming gaps and tight junctions. The compaction process marks the beginning
of the embryonic cell differentiation where a separation of cells forming an inner and
outer cell masses occurs. This new formation of blastomeres, termed the morula, is now
ready to leave the site of fertilization and enter into the uterus on day 3 in the human and
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the mouse (Hardy and Spanos, 2002), and day 4 in sheep and cattle (Rowson and Moor,
1966).
At the 32-cell stage of embryonic development, a fluid-filled cavity begins to
appear marking another developmental milestone from morula to blastocyst. With the
formation of the blastocyst there is a clear distinction of the pluripotent inner cell mass
which will become the embryo proper, and the outer cell mass or trophectoderm that will
transition into the extra-embryonic membranes. The trophectoderm cells will make the
first physical and physiological contact with the maternal uterine luminal epithelium and
initiate attachment (Paria et al., 2001). At the blastocyst stage, the conceptus is still
enveloped by the zona pellucida, which adds to the structural integrity, but must be shed
to allow for the continuation of development and attachment. Although the zona
pellucida becomes hardened after the invasion of the ovum by the sperm, it is not
impenetrable (Hastings et al., 1972; Sinowatz et al., 2001). In 2007, Loureiro and
colleagues observed that during times of heat stress or innate immune challenges
resulting in the secretion of the proinflammatory cytokine tumor necrosis factor- α (TNFα), the zona pellucida alone is unable to protect the embryo from apoptosis. Hansen
(2007) found that there is a decrease in vulnerability to environmental stresses for the
embryo as it ages and develops. This decreased susceptibility to detrimental effects on
the embryo is yet to be defined, but it could be that as the embryonic genome is
completely turned on, the embryo gains the protection of a very early innate immune
system.
After hatching of the blastocyst from its zona pellucida, on day 8 of gestation in
the sheep, the embryo becomes free floating and moves through an ever changing fluid
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environment, lacking a blood supply, and without direct cell to cell contact with the
reproductive tract (Böving, 1959). During this time the embryo continues to develop and
differentiate, gaining its nourishment from uterine secretions called histotroph. The
embryo’s cellular activities including cell division, gene expression, and metabolic
processes are directly influenced by the uterine environment, regulated by locally
produced growth factors. Continued blastocyst development and differentiation,
attachment, recognition and maintenance of pregnancy require an effective maternalembryonic dialogue mediated by these same growth factors. By day 16 of pregnancy in
the sheep the initiation of attachment has begun (Böving, 1959; Boshier, 1969).
There are many criteria that have to be met in order for attachment to occur. The
“window of opportunity” for uterine receptivity is defined as the limited time by which
the uterine environment is optimal for the receiving embryo to adhere to the uterine
luminal epithelium. Prior to implantation the blastocyst becomes situated in close
proximity with the uterine epithelium allowing for cross-talk to occur followed by the
very first connection between the conceptus and the endometrium referred to as
apposition. In ruminants, apposition is restricted to uterine epithelial glandular sites
called aglandular caruncular and glandular intercaruncular tissues which will be the
superficial sites of attachment and placentation (Wimsatt, 1950; Senger, 2003). As
Lefèvre and Boulay (1993) demonstrated in the pig, uterine differentiation at the time of
apposition, adhesion, and implantation is coordinated maternally by an increase in
vascular permeability and the secretion of P4 and estrogen in a spatiotemporal manner,
and embryonically by production of IFN-τ.
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Maternal Recognition of Pregnancy
The communication between the female and the developing embryo to ensure
survival of the conceptus through prolonging the life of the CL and resulting
establishment of pregnancy can be defined as maternal recognition of pregnancy. At day
13-20 of gestation in domestic livestock species, the developing embryo begins to
produce INF-τ, an anti-luteolytic hormone that blocks uterine PGF2α production thereby
prolonging the life of the CL. Synchrony between the conceptus and the uterus is
essential, as well as optimal physiological conditions that will allow acceptance of each
other (Roberts et al., 1996). The process of maternal recognition of pregnancy is a
species specific event: in species such as humans, swine, sheep and cattle the embryo
provides the recognition signals via the production of hormonal signals such as human
chorionic gonadatropin (hCG), E2 and IFN-τ respectively. As Bazer and Thatcher
observed (1977) the embryo in swine produces E2, as well as stimulates uterine secretions
of PGF2α causes an extension of the lifespan of the CL. However, in the human being,
hCG is secreted from the trophoblast cells of the developing embryo and takes a direct
action by stimulating a continual secretion of P4 by the CL. In comparison, IFN-τ in
ruminants indirectly affects the CL by inhibiting endometrial secretion of PGF2α (Bazer,
1998). Regardless the origin of the signal, the main objective of embryonic/uterine
dialogue is to ensure the lifespan of the CL is prolonged, which in turn continues its
secretion of P4.
In cattle and sheep, IFN-τ is an anti-luteolytic that acts on the endometrium in a
paracrine fashion to inhibit the pulses of PGF2α induced by oxytocin. In addition to
being a signal for maternal recognition of pregnancy, IFN-τ also has antiviral,
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antiproliferative, and immunomodulatory properties. In the ewe, mononuclear
trophectoderm cells in the embryo synthesize and secrete IFN-τ between day 10 and 21
of gestation, with a maximal production on day 14-15. On day 10 the embryo begins
elongating from a spherical shape to a more filamentous one as it initiates production of
IFN-τ (Spencer et al., 2004). Spencer and colleagues (1996) observed an increase in
IFN-τ secretion (ng/uterine flushing) for spherical to tubular to filamentous growth,
resulting in 312ng, 1380ng, and 4455ng, respectively.
Much research has been directed towards delineating the mechanism by which
IFN-τ inhibits luteolysis. Spencer and Bazer (1995) found that the anti-luteolytic effect
of IFN-τ is a result of suppression of estrogen and oxytocin receptors in the endometrium.
Indirectly, IFN-τ inhibits estrogen receptor gene transcription thereby precluding
oxytocin receptor expression by estrogen and oxytocin receptors in the endometrium,
which consequently diminished peak frequency and amplitude of endometrial PGF2α
secretion (Spencer and Bazer, 1995; Fleming et al., 2001, 2006).
Bacteria
Bacteria consist of mycoplasms, cyanobacteria, gram-positive bacteria, and gramnegative bacteria, and with a few exceptions, bacterial cell walls composed of
peptidoglycan. Peptidoglycan, also called murein, is a large polymer consisting of
interlocking chains of identical peptidoglycan monomers. Each peptidoglycan monomer
is made up of two joined amino sugars, N-acetylmuramic acid (NAM) and Nacetylglucosamine (NAG), with a polypeptide attached to the NAM. Peptidoglycan
monomers are joined by the enzyme transglycosidase and held together via glycosidic
bonds. Once polymers have been formed, peptide cross-linkages protruding from the
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NAM molecules hold the peptide together with help from transpeptidase. This side-byside and layered bonding gives the cell wall strength and semi-rigidity. Peptidoglycan, or
its fragments, can induce a multitude of biological effects such as inflammation, fever
lethargy, decreased appetite, and enhanced immune responses (Royet and Dziarski,
2007).
Bacteria are classified as gram-positive or gram-negative based on the percentage
of peptidoglycan in its cell wall. The cell wall of gram-positive bacteria consists of 60-80
% peptidoglycan, whereas the peptidoglycan content of the gram-negative bacteria is 1020 % (Royet and Dziarski, 2007). The outer surface of the peptidoglycan is studded with
proteins specific to the particular strain and species of bacteria it is present on, thus it
serves as a biomarker that alerts the innate immune system of the host cell to its presence.
Along with lipoteichonic acid (LTA), peptidoglycan not only increases the structural
integrity and strength of the cell wall, but is important in the prevention of osmotic lysis,
the mechanism of action of some antibiotics. Peptidoglycan is not the only constituent in
the bacterial cell wall. Kengatharan et al., (1998) showed that peptidoglycan by itself has
no effects on eliciting a response by a host organism’s innate immunity. However, when
combined with LTA, peptidoglycan can initiate an immune response by activating
leukocytes and stimulating the generation of proinflammatory cytokines. Because of the
synergistic effects of peptidoglycan and LTA, collectively they are referred to as the
peptidoglycan-polysaccharide complex (Tizzard, 2004).
Infections from gram-positive bacteria like bacillus, listeria, streptococcus, and
staphylococcus, which have been linked to mastitis, cause detrimental health effects and
even death. Economic losses for the dairy industry alone are estimated at well past $2
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billion dollars (Stevenson, 2001). In addition to the loss from discarded milk, mammary
infections initiate immune responses that possibly have ramifications in early embryo
loss and death of the dam (Morris et al., 2002).
A bacterium has its own innate defense mechanism that is species and strain
specific. The carotenoid pigments that give Staphylococcus aureus, a major contributing
bacterium to mastitis, its golden color and group B streptococci (GBS) its orange tint,
actually cause a shield like effect against the toxic oxidants produced by neutrophils that
are used to kill bacteria. In addition, some bacteria, such as Staphylococcus aureus and
Streptococcus pyogenes themselves produce a powerful endotoxin called leukocidin,
which causes damage to the cytoplasmic membrane of the phagocyte or lysosome of the
host. This membrane attack results in the phagocyte being killed by its own enzymes.
There are also bacterial actions which prevent the formation of a membrane attack
complex (MAC). Shigella and Salmonella can initiate macrophage apoptosis, as well as
produce its own protein that binds to a portion of the antibody allowing the bacteria to
become coated with antibodies in a way that it does not result in opsonization, thereby
evading the innate immune system (Todar, 2002).
A unique part of bacteria pathogenicity is the production of virulence factors that
damage the host. To not only cause disease, but also damage, bacteria must be able to
maintain a reservoir before and after infection, leave the reservoir to gain access to the
new host, and colonize the body. Another such virulent factor includes the ability of the
bacteria to produce pathogen-associated molecular pattern (PAMP) that bind to host
defense cells causing them to synthesize and secrete proinflammatory cytokines and
chemokines. Although this secretion of cytokines and chemokines are helpful to the
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immune system of the host, it is still a process that results in tissue damage, and at high
concentrations host death. Exotoxins are protein toxins that are either released from
living bacteria or upon bacterial lysis. Exotoxins can serve as superantigens, causing
severe damage to host cell membranes (Wilson et al., 2002).
Innate Immunity
Innate immunity refers to the host defense mechanism that all living creatures are
born with and is the initial response by the body to eliminate any pathogenic molecule
(antigen-nonspecific) and prevent infection. This host immunity is used immediately
upon recognition of a foreign invader and is fully activated within several hours after
exposure (Wira et al., 2005). Even though innate immunity is antigen-nonspecific,
defense cells such as macrophages, neutrophils and monocytes do recognize a few highly
conserved structures present on a variety of different microorganisms. These conserved
structures or PAMP such as lipopolysaccharide (LPS), peptidoglycan, LTA, mannose,
bacterial DNA and glucans are all that is required to initiate the correct cascade and begin
the host immune attack (Janeway and Medzhitov, 2002).
In order to protect against infection, the host organism must be able to recognize
self from non-self by identifying molecules that are species and strain specific for a
particular type of pathogen, as well as those molecules that are found within the host
PAMP (Janeway and Medzhitov 2002). Pattern-recognition receptors (PRR) of defense
cells bind PAMP, peptidoglycan and teichoic acid, triggering innate immune responses
(fever, inflammation and phagocytosis) and activate the complement and lectin defense
pathways. In all, the innate immune system is thought to be able to recognize 103
molecular patterns (Tizzard, 2004). Additionally, defense cells within a host, like
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macrophages, have pattern recognition receptors on the outer cell membrane called tolllike receptors (TLR) and internally in the cytoplasm called nucleotide-binding
oligomerization domain proteins (NOD) (Akira, 2004).
Signaling PRR bind a vast number of microbial molecules, both from bacterial
and viral agents (Nakayama et al. 1993). The most notably and researched of the
signaling pattern-recognition receptors are TLR. The binding of microbial molecules to
their corresponding TLR promotes both the synthesis and the release of intercellular
regulatory molecules such as cytokines, which are crucial to the initiation of the innate
and adaptive immune systems (Akira 2004). Aderem and Smith (2004) summarized the
identification of 11 TLR. These TLR can work independently or with one another
depending on the PAMP presented. TLR are found not only on cell surfaces, but also in
the membranes of the endosomes used to degrade pathogens. Work by Pasare and
Medzhitov (2004) showed that TLR 2 and TLR 6 work together during the recognition
and binding of the LTA and peptidoglycan PAMP, with TLR 2 as the primary signal to
initiate immune response and subsequent binding with TLR 6 a secondary reaction
(Takeda, 2004). The binding of a pathogen to its corresponding TLR transmits a signal
to the macrophage’s nucleus via a nuclear factor, NF-κB, which in turn causes the
induction of gene expressions that code for specific cytokine synthesis (Takeda and
Akira, 2005). Upon their induction, cytokines bind to their receptors on other cells,
including those of the defense system, furthering the innate immunity cascade.
NOD are cytostolic proteins that allow intracellular recognition of peptidoglycan
components. There are two NOD (Mueller and Podolsky, 2005). NOD 1 is essential in
the recognition of peptidoglycan containing muramyl dipeptide NAG-Nam-γ-D-
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glutamyl-meso diaminopimelic acid; a common peptidoglycan monomer component in
all gram-negative bacteria and a few gram-positive bacteria. On the other hand, NOD 2
recognizes a peptidoglycan component that is found in almost all bacteria, muramyl
dipeptide NAG-NAM-L-alanyl-isoglutamine (Murillo et al., 2003).
In 2003, Girardin and colleagues observed that PAMP on peptidoglycan
fragments that are in systemic circulation bind to TLR on macrophages and are broken
down into muramyl dipeptides and endocytized. NOD 1 and/or NOD 2 located in the
cytosol bind to the muramyl dipeptides leading to the activation of those genes that code
for proinflammatory cytokines. The participation of NOD 1 or NOD 2 in the cytoplasm
is carried out in a similar fashion as the cell surface TLR.
Cytokines are multifunctional, pleiotropic and redundant proteins that are
activated during an innate immune response. Cytokines act as intracellular and
intercellular signaling molecules that are synthesized and secreted by a variety of
different cell types, as well as act on a range of target cells (van Deventer et al., 1990). A
great example that shows the versatility of cytokine production and action is tumor
necrosis factor-α (TNF-α), which is synthesized and secreted mainly by macrophages and
mast cells. Red blood cells (RBC) are the only known cells that do not contain TNF-α
receptors (Tizzard, 2004). Several cytokines can illicit the same cellular response,
allowing an immune response to be activated via several different pathways, yielding in
the same result. Additionally, the same cytokine has the ability to be a regulatory factor
in a number of different cellular functions. While some cytokines initiate and amplify the
response, others sustain or attenuate it (proinflammatory), and some cause it to resolve
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(anti-inflammatory). Depending on the origin of the cytokine synthesis stimulation,
different patterns of cytokine release have been observed (Gruys et al., 2005).
Cytokines can be placed into one of two subcategories termed either T-helper 1
(Th-1) or T-helper 2 (Th-2) cytokines. Th-1 cytokines are primarily proinflammatory
including TNF-α, interleukin-1 (IL-1), interleukin-2 (IL-2), interleukine-8 (IL-8), and
interferon-γ (IFN-γ). Th-2 cells secrete interleukin-4 (IL-4), interleukin-5 (IL-5),
interleukin 6 (IL-6), and interleukine-10 (IL-10), which down-regulate the inflammatory
response (Mosmann and Coffman, 1989; Raghupathy, 1997). As stated by Agarwal et al.
(2000) a successful pregnancy is the result of a fine balance between Th-1 and Th-2 type
cytokines that are involved throughout growth, development and maternal tolerance of
the conceptus.
Cytokines such as TNF-α, IL-1, IL-6, IL-12 and chemokines (glycoproteins with
leukocyte activation and chemotactic activity) such as IL-8 are stimulated immediately
after initiation of the innate immune system (Papanicolau et al., 1998). Upon activation
of the cytokine cascade, not only is the innate immune system responsive, but the
initiation of the acute phase response (APR) begins. The participating cytokines are
considered to be proinflammatory, because they promote production and release of other
cytokines and chemokines to amplify the immune response. Chemokines, like IL-8, are
known to promote inflammation by acting chemotactically, enabling white blood cells
(WBC) to leave the blood and by attracting those same WBC to the site of trauma or
infection. Moreover, these same cytokines and chemokines not only play roles in a vast
number of immune responses, but they are vital for homeostasis. As studied by
Bagavandoss et al., (1988) and later by Murdoch et al., (1997), TNF-α is critical in
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ovulatory processes. Additionally, IL-1 has positive effects on the enhanced growth of
fibroblasts, glial cells and vascular smooth muscle, all of which aid in daily cell growth
and maintenance (Aggarwal and Natarajan, 1996).
TNF-α is the first cytokine to be synthesized and secreted by macrophages upon
initiation by NF-κB in response to TLR or NOD binding. TNF-α is an essential mediator
of inflammation working both independently and synergistically with IL-1 (Gupta, 2001).
A local increase in TNF-α near the site of infection or trauma causes an inflammatory
response, including heat, pain, and swelling in the surrounding tissue. This is
accomplished by TNF-α causing an increase in production of angiotensin II (Ang II) and
prostacyclin (PGI2), both vasodilators, by local endothelial cells. Ang II and PGI2 cause
capillaries to leak (Kuwano et al., 2004). This leakage allows neutrophils and other
plasma proteins to enter tissue and augment the immune response. In addition, TNF-α
acts on neutrophils directly by enhancing their ability to kill microbes and increasing
adherence to vascular endothelium, as well as chemotactically attracting them to the site
of tissue damage. Systemic TNF-α stimulates mast cells and macrophages to produce
additional cytokines such as IL-1 and IL-6 (Blatteis, 2007).
Produced primarily by macrophages, IL-1 has two isoforms IL-1α and IL-1β. IL1β is produced by 50-fold more than its counterpart IL-α, and while IL-1β is secreted into
systemic circulation, IL-1α remains attached to the macrophage from which it was
produced. The mRNA for both isoforms of IL-1 increase significantly within 15 minutes
after exposure to stimulus, continuing until it reaches its peak production at 3 to 4 hours
post induction (Baggiolini, 2001).
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Once induced and circulating systemically, IL-1 can work independently
or synergistically with other cytokines like TNF-α. During times of infection, along with
TNF-α, IL-1 escapes from the bloodstream and causes a multitude of sickness behaviors.
Synergistically they act on the brain to cause fever, lethargy, decreased appetite and
general malaise (Uhlar and Whitehead, 1999). In addition, IL-1 and TNF-α are
responsible for the activation of the production of another proinflammatory cytokine, IL6. As Steel (1994) described, IL-1 not only acts on muscle cells to mobilize amino acids
causing pain and fatigue, but also on hepatocytes to enhance the production of acute
phase proteins to assist with the host innate immunity, the later reaction accomplished
indirectly with the stimulation of IL-6.
IL-6 is secreted from macrophages after the synergistic stimulation of TNF-α and
IL-1, and bacterial endotoxins. IL-6 acts in a negative feedback fashion on TNF-α and
IL-1 to control the immune response (Heinrich et al., 1990). Additionally, McWaters et
al., (2000) showed that IL-6 regulates the transition from a neutrophil-dominated process
early in inflammation to a macrophage-dominated process late, and for that is considered
the major mediator of the acute phase reaction.
The mammalian acute phase response (APR) is the first line of systemic defense
in response to infection, physical trauma, malignancy, myocardial infarction and surgery
(Koj, 1985). APR is characterized by a wide range of neuroendocrine, hematopoietic,
metabolic and hepatic changes (Ceciliani et al. 2002). Neuroendocrine changes observed
are fever, poor appetite, somnolence, as well as increases in adrenocorticotropic hormone
(ACTH), cortisol and catecholamine concentrations. In addition, an elevation in the
circulating concentrations of hepatically synthesized acute phase reactants called acute
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phase proteins (APP) are observed at this time (Ceciliani et al., 2002). Optimally, the
APR should begin several minutes after initial immune activation. Gruys et al. (2005)
found that vaccinations and starvations can also cause initiation of APR. Regardless of
the stimulation, these reactions aim to prevent ongoing tissue damage, isolate and destroy
the invading microorganism, and activate the repair processes necessary to restore
homeostasis in the host (Baumann and Gauldie, 1994). The APR begins immediately
after a pathogenic or pathogenic-like stimuli has been initiated by proinflammatory
mediators such as cytokines like IL-6, IL-1β , IL-8, TNF-α, INF-γ , transforming growth
factor β (TGF-β ), glucocorticosteroids and anaphyltoxins (Kushner 1993; McCormack
et al., 1996; Wigmore et al., 1997; Gabay and Kushner, 1999). The local inflammation in
both cancer and infection is accompanied by APP upon activation by cytokines
(Cavaillon and Duff, 1999).
Cytokines released from immune defense cells are transported through the blood
and stimulate hepatocytes in the liver to synthesize and secrete APP. Upon stimulation of
the APR the first APP are usually detected within one to two hour(s), and continue for
one to two day(s). In addition to the APP production in the liver there is extrahepatic
synthesis by macrophages, endothelial, and smooth muscle cells (Winter et al., 2006).
As shown by Wilson et al. (1984), APP are species specific. APP have been
defined as any protein whose plasma concentrations increases (positive acute-phase
proteins; fibrinogen, serum amyloid A, albumin, C-reactive protein) or decreases
(negative acute-phase proteins; albumin, transferrin, insulin growth factor I) by at least 25
percent during an inflammatory disorder (Morley and Kushner, 1982).The major APP for
humans are C reactive proteins (CRP) and serum amyloid A (SAA), for mice it is SAA,
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in cattle they are SAA, haptoglobin and lipopolysaccharide binding protein while in
sheep both haptoglobin (Hp) and SAA are APP. APP are considered biomarkers for
infection, functioning as soluble PRR. Additionally, each APP has individual actions
against invading organisms. SAA is a strong opsinizing agent against invading
pathogens, whereas Hp binds hemoglobin, and sequesters the iron within hemoglobin,
preventing iron-utilizing bacteria from benefiting from hemolysis (Eaton et al., 1982;
Uhlar and Whitehead, 1999). The production of APP enable the body to recognize
possible pathogens early after infection, prior to full activation and implementation of a
complete immune response. As with APR, the main stimulators of APP production are
the inflammation-associated cytokines, which are produced as a result of, and participate
in, the inflammatory processes (Tizzard 2004).
During the inflammatory response, TNF-α and IL-1 stimulate the anterior
hypothalamus of the brain; the portion of the brain that regulates body temperature (Cid,
1992). This stimulation results in an increased production of prostaglandins, which lead
to sympathetic nerve stimulation and vasoconstriction of skin vessels, which ultimately
leads to an increase in body temperature, or a phenomenon that is most commonly
referred to as fever (van Deventer et al., 1990).
Within certain parameters, fever is not detrimental, but actually beneficial. Fever
causes the host environment to move above the optimal temperature for a number of
microorganisms, thus slowing down their growth. While the growth rate of the invading
pathogen has decreased, the host body’s defense system has a chance to gain ground in
the elimination and removal of the pathogen. Fever continues the ongoing secretion of
proinflammatory cytokines by its direct action in the production of heat shock proteins.
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An increase in body temperature causes an increase in enzymatic activity that in turn
results in an increase in the host metabolism. By speeding up the metabolic rate of the
host we can see a rise in defense cell and antibody production, allowing for a greater
immune response. However, a fever that becomes too high can cause extensive and
possibly irreversible damage to the host. At an excessively high body temperature, or
chronic fever, enzymes along with other proteins can become denatured, an
overabundance of cytokines can be stimulated resulting in tissue damage that may not be
able to be repaired, multiple organ failure occurs as a result of tissue damage and septic
shock or systemic inflammation response syndrome (SIRS) occurs (Kengatharanetal,
1998; Pechlaner, 2002) (Kluger et al., 1995). Over 210,000 people a year in the United
States alone die from septic shock with 45% of cases of septicemia due to gram-positive
bacterial infections (Morris, 2001).
Adaptive Acquired Immunity
Unlike the quick acting innate immune system, the adaptive or acquired immune
system is just as its name implies, acquired over time. Adaptive immunity is an antigenspecific mechanism that takes several days to weeks to become active. Once the innate
immune response is activated via pathogen detection, and the acute phase response has
been initiated, the host body is then able to accurately begin to determine the specifics of
the given antigen and correspondingly trigger an adaptive immune response.
Within the adaptive immune response there are two subcategories:
humoral and cell-mediated immunity. Humoral immunity produces antibodies in
response to a specific antigen. Immunogens, antigens capable of provoking an immune
response, have specific areas on their surface, called epitopes, which will react with
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receptors on the host lymphocytes and antibodies (Pasare et al., 2004). The host body
recognizes an antigen as foreign only when immunogen epitopes bind to their receptors
on T-lymphocytes (T-cells) or B-lymphocytes (B-cells) via epitope-specific receptor
molecules. Unlike the receptors on T-cells that only recognize epitopes, B-cell receptors
are able to directly bind epitopes on antigens allowing for the mass production of
antibodies for that given antigen. It is the B-cells that mediate the production of
antibodies via activation of the humoral pathway (Goldsby et al., 2003).
While the humoral pathway is mediated by B-cells, the cell-mediated immunity is
carried out by T-cells. T-cells mediate the activation of macrophages and natural killer
cells, the production of cytotoxic T-lymphocytes and cytokines all in response to an
immunogen. Furthermore, T-cells have the ability to recognize immunogen epitopes and
discriminate self from non-self via major histocompatible complex I molecules (MHC I)
(Huber et al., 1976).
MHC I molecules are produced by all nucleated cells in the host. MHC I
molecules join themselves with a variety of peptide derived cytocylic proteins from
degraded pathogens via proteosomes. Once attached, the MHC I molecules along with
the peptide epitope is able to be recognized by a complementary-shaped receptor on the
surface of a naïve T-8 lymphocyte. This naïve T-8 lymphocyte then has the ability to
clone the presented peptide epitope. The T-8 lymphocyte is able to produce mature Tcells that will have receptors for the specific antigen and be able to bind the pathogen
epitope directly. Thus, the initiation of the adaptive immune system via cell-mediated
immunity has begun (Marrack and Kappler, 1993). An added feature of MHC I
molecules is their function, when unbound, as a marker for the immune system,
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collectively, to differentiate between cells that are self from those that are foreign. All
cells that are not marked with unbound MHC I molecules are identified by natural killer
cells (NKC) as pathogenic and phagocytized.
In addition to the MHC I molecules that aid in cell-mediated immunity in the
recognition of immunogens, both the humoral and cell-mediated immune systems also
utilize MHC II molecules. Unlike MHC I molecules, MHC II molecules are only found
in macrophages, dendritic and B-cells, and bind peptides derived from extracellular
pathogenic proteins. Once bound, MHC II molecules interact exclusively with CD4+ T
cells (helper T cells). The helper T cells then help to trigger an appropriate immune
response which may include localized inflammation and swelling due to recruitment of
phagocytes or may lead to a full-force antibody immune response due to activation of B
cells (Amilla et al., 1998).
Summary
Bacterial infections, like mastitis, continue to be costly, unresolved problems for
the dairy industry. Bacterial cell wall components peptidoglycan and LPS can illicit
innate immune system responses that can contribute to a number of homeostatic
disturbances. Fever, lethargy, loss of appetite, and general malaise seem to be consistent
characteristics of bacterial infections, and can act as markers that show an acute phase
response has been initiated via cytokines, chemokines and acute phase proteins.
Additionally, bacterial pathogens that invade pregnant animals may also be potentially
dangerous to the embryo as well. The aim of this study was to further examine possible
embryonic loss due to mastitis and in doing so gain a better understanding of the
mechanisms behind such loss.
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Figure 1. Innate and Acquired/Adaptive Immune Response Summary
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Introduction
Barker et al. (1998) investigated the influence bacterial infections, such as
mastitis, has on reproductive performance. Dairy cows having contracted mastitis post
partum during early lactation, but before the first artificial insemination (AI), required on
average 20 more days before showing visible signs of estrus. Additionally, if cows
contracted mastitis between the time of the first AI and confirmation of pregnancy, they
required 1.5 more inseminations before pregnancy was confirmed, thus increasing the
length of the breeding period by approximately 55 days. Moreover, Barker et al.
concluded that bacterial infections have a negative affect on reproductive performance.
To determine the possible bacterial induced mechanism affecting reproductive
performance, Stewart et al. (2003) examined the immune response and its potential
physiological influences in the early pregnant ewe. Using three concentrations, 15,30,
and 60 µg/kg body weight, of a bacterial cell wall component, peptidoglycanpolysaccharide (PG-PS), injected intravenously, an immune response was illicited.
Through plasma samples collected via jugular blood, Stewart et al. were able to show that
all PG-PS concentrations caused an increase in body temperature, as well as increases in
cortisol and PGFM, a Prostaglandin-F2α metabolite. Furthermore, plasma concentrations
of progesterone decreased in all treated ewes compared to that of controls. Pregnancy
loss was analyzed and found to be 0% in controls and those ewes treated with 15 µg/kg
body weight PG-PS compared to a combined 40% in those dosed with 30 and 60 µg/kg
body weight PG-PS.
Based on previous findings from Barker et al. (1998) and Stewart et al. (2003)
showing that an immune reponse due to a bacterial infection occurs and that such an
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occurance can compromise reproductive performance, Holásková et al. (2004) examined
the time at which an immune response to a bacterial infection occurs; during the innate or
the adaptive immune response. If a response was during the adaptive period, it was
hypothesized that it may be possible to vaccinate against a bacterial invasion, thus
preventing pregnancy loss. Challenging ewes with 60 µg/kg body weight PG-PS either
after immunization with 30 µg/kg body weight PG-PS or heat killed bacterial cells,
Holásková et al. found that pregnancy loss occurred more in those animals who were
vaccinated. Evidence from this experiment proved that an insult from a bacterial
invasion resulting in embryonic loss occurs early during the innate immune response.
To further the understanding of when and how an innate immune response can
lead to pregnancy loss during a bacterial infection, Rogers (2006) looked at the
inflammatory mediator TNF-α and acute phase protein SAA. By monitoring the
production of TNF-α and SAA, Rogers was able to determine when an immune response
commenced and if the response was a systemic or local response, regardless of site of
PG-PS injection. A catheter was placed in the jugular vein, as well as the saphenous vein
of the right hind leg to allow for sampling of the caudal vena cava. Since the circulating
blood travels from the reproductive tract into the caudal vena cava, an estimate of
inflammatory mediator and hormone concentrations could be analyzed as that of local
exposure to the tract. After an intravenous injection of 30 µg/kg body weight PG-PS
given in the jugular vein contralateral to the catheter, data revealed that ewes challenged
with PG-PS experienced an increase in both TNF-α and SAA concentrations when
compared to controls. Moreover, there was also a significant increase in concentration of
TNF-α in blood from the caudal vena cava compared to that of the jugular. Therefore,
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Rogers concluded that there was an increased local exposure to TNF-α of the
reproductive tract, and with the increase in SAA concluded that an immune response due
to a bacterial infection acts through the acute phase response.

Objectives

At 5 and 6 days post coitus (dpc), the embryo is a free-floating entity vulnerable
to maternal immune responses. As the reproductive tract becomes a site for an
inflammatory reaction, concentrations of pro-inflammatory cytokines, chemokines,
localized invasion of immune cells, as well as systemic increases of acute phase proteins
(APP) will increase. The null hypotheses for this experiment is injection of 5 and 6 dpc
pregnant ewes with peptidoglycan-polysaccharide (PG-PS) does not illicit a difference in
concentration of proinflammatory cytokines, tumor necrosis factor-α (TNF-α), and acute
phase proteins (APP), serum amyloid A (SAA) and haptoglobin (Hp), between plasma
collected from the jugular vein (representative of systemic circulation) or that from the
caudal vena cava via saphenous vein (representative of local reproductive tract
circulation). Moreover, increased TNF-α, SAA, Hp concentrations in blood plasma of 5
and 6 dpc pregnant ewes was hypothesized to not either directly or indirectly cause early
embryo loss. The main objectives of this project were to characterize the effects of an
acute phase response (APR) of the innate immune system, via cytokine production, acute
phase proteins, behavioral changes, and fever, in early pregnant ewes, after intoxication
with PG-PS, to investigate for an effect of APR on early embryonic loss.
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Materials and Methods
Thirty mature Suffolk ewes, ~ 80 kg BW, (WVU IACUC #9801-06) were fed
corn silage and haylage twice a day and had access to fresh water ad libitum. Ewes were
housed with a vasectomized ram fitted with a marking harness to aid in detection of
estrus. Fifteen ewes that had exhibited two consecutive, estrous cycles of 16 to 18.5 days
in length were given two, 1 cc (5 mg per mL) intramuscular injections of PGF2α
(Lutalyse®, Pharmacia and UpJohn, New York, NY) 3 hours apart (Inskeep et al., 1983)
to synchronize estrus. Every 12 hours ewes were observed for signs of mounting.
Marked ewes were removed from the flock and mated by two fertile rams. A replicate of
15 ewes was synchronized and bred seven days later (12/10-12/11/06). In each group, 10
ewes successfully mated.
Day of the first breeding was denoted as 0 dpc. On 4 dpc, ewes were anesthetized
with Diazepam®, 0.3 mg/kg BW iv, (Hoffmann-La Rouche Inc., Nutley, NJ) and
Ketamine®, 0.7 mg/kg BW, (Phoenix Pharmaceuticals Inc., Mountain View, CA).
Once mildly sedated ewes were maintained anesthetized using isoflurene gas via an
intratracheal tube. The area around the right hock leg was shaved and scrubbed with
Betadine® (The Perdue-Frederick Company, Stamford, CT), and treated with ~3 mL
Lidocaine® (Butler Company, Columbus, OH). The skin over the hock was tented using
a pair of forceps and slit approximately 1 cm. The saphenous vein was isolated by blunt
dissection, incised using a pair of iridectomy scissors. A polyvinyl catheter (id 0.040” and
od 0.070”) (Cole-Parmer, Vernon Hill, IL) was inserted into the saphenous vein 55 cm to
sample blood draining the reproductive tract (Benoit and Dailey, 1991) and anchored
with dissolvable suture. Catheters were flushed with 2 cc of heparinized saline and

31

capped with an 18 gauge, 1 inch needle with a filed off tip fitted into the tube. The
catheter site was closed with 1 to 2 sutures and dressed with Furazolidone® (Veterinary
Products Laboratories, Phoenix, AZ), covered with 4” by 4” sterile gauze pads and
wrapped with Vetrap® (3M®, St. Paul, MN). The right jugular fossa area was scrubbed
with Betadine®, and the right jugular vein was catheterized with an I-CATH Intravenous
Placement Unit with Stylet® (CharterMed, Inc., Lakewood, NJ). The area around the
catheter was treated topically with Furazolidone®, covered with 4” by 4” sterile gauze
pads and wrapped with Vetrap®. Ewes recovered immediately following surgery and
were housed post-operatively two ewes per pen at the Food Animal Research Facility
with a room temperature maintained at ~ 18 °C.
On 5 dpc ewes were assigned to one of two treatment groups per pen: controls
received 10.67 cc of 0.9% saline and treated ewes received 10.67 cc of 60 µg/kg PG-PS
(BD Lee Laboratories, Grayson, GA) in the jugular vein contralateral to the catheter.
Blood samples (6-8 ml) were collected into EDTA treated tubes every fifteen minutes
post challenge for 120 minutes, every hour to 12 hours, and every 12 hours until 48
hours. Samples were centrifuged, and plasma was collected and stored at -20ºC until
assayed. Changes in body temperature, behavior and/or physical appearance were
recorded. At 48 hours, saphenous and jugular vein catheters were removed and the sites
were dressed topically with Furazolidone®, covered with 4” by 4” sterile gauze pads and
wrapped with Vetrap®. Ewes were returned to the sheep facility and placed with a
vasectomized ram fitted with a marking harness. At days 14 and 21 of gestation, jugular
blood samples were collected in EDTA treated tubes, in addition to transrectal
ultrasonography for detection of pregnancy on day 21 (Schrick and Inskeep, 1983).
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Assays
Concentration of P4 in jugular plasma (100 µl of sample/tube) was determined by
radioimmunoassay (Sheffel et al., 1982). Assay sensitivity was 0.29 ng/ml and intraassay and inter-assay coefficient of variation averaged 7% and 14.8% respectively among
three assays.
TNF-α was assayed in both jugular and caudal vena cava plasma samples (100 µl
sample/tube) using a non-equilibrium RIA (Kenison et al., 1990) at the USDA Growth
Biology Laboratory (Beltsville, MD). Samples were analyzed in duplicate with an intraassay coefficient of variance less than 7 %.
SAA concentrations were determined using a multispecies SAA solid phase
ELISA kit (Invitrogen Corporation, Carlsbad, CA). The protocol supplied with each kit
was followed to process duplicate plasma samples (4 µL sample + 396 µL S/CD buffer,
then 5 µL sample + 145 µL S/CD buffer) diluted 1:3000. SAA concentrations were
reported in ng/mL with an assay sensitivity of 0.3 µg/mL and an intra-assay coefficient of
variance of 9.8 % among ten assays.
Hp concentrations were determined using multispecies Hp colormetric kits (Phase
™ Range, Tri-Delta Diagnostics Inc., Morris Planes, NJ). Plasma samples were diluted
1:3 (25 µL sample + 50 µL diluent buffer) and tested in duplicates. Hp concentrations
were reported in mg/ mL. Hp ELISA sensitivity was 0.05 mg/ml, with an intra-assay
coefficient of variance of 6.9 % for two assays.
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Statistical Analysis
Primary Null Hypotheses:
1.

The concentration of TNF-α, SAA and Hp in blood plasma collected from either

the jugular vein or the caudal vena cava via saphenous vein for a given time period does
not differ between 5 and 6 dpc pregnant ewes intoxicated with an injection of PG-PS or
those given a sham injection of .9% saline.
2.

Intoxication of 5 and 6 dpc pregnant ewes with PG-PS does not illicit a difference

in TNF-α concentrations between plasma collected from the jugular vein or that from the
caudal vena cava via saphenous vein.
3.

Increased TNF-α, SAA, Hp concentrations in blood plasma of day 5/6 pregnant

ewes does not contribute to early embryo loss.
Data for concentrations of P4, TNF-α, SAA, and Hp were analyzed by repeated
measures ANOVA GLM procedure of SAS (SAS Inst., Cary, NC). P-values less than
0.05 were considered significant. Immune response was determined by fever, increases
in SAA and Hp concentrations, as well as veterinary diagnostic hemagrams and large
animal blood chemistry panels (Cornell University, Animal Health Diagnostic Center,
Ithaca, NY).
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Results
Body temperature was higher (40.3°C) for treated ewes compared to the average
controls ( 39.1°C) at the peak of the fever response. Body tempearture increased in
treated ewes beginning at ~3 hours post treatment, peaked at 12 hours post, and had
resumed to normal parameters at 24 hours post. In addition, treated ewes showed a
decrease in appetite, lethargy, and general malaise. A muco-purulant vaginal discharged
was observed in all treated ewes at ~3 hours post intoxication, persistedfor 24 hours, and
cleared to a watery discharge at 48 hours. Thus, an innate immune response was initiated
and localized inflammation occurred within the reproductive tract..
At 14 dpc all ewes in both treatment and control groups exhibited P4
concentrations, mean 1.60 ng/ mL and 2.14 ng/ml respectively, indicative of pregnant
ewes (Bassett et al., 1969) (Table 1). At 21 dpc, P4 concentrations decreased
significantly <0.74 ng/ml (p<0.01) in all treated ewes, but had increased to 2.40 ng/ml in
control ewes. Viable embryo(s) and CL were observed in all control ewes and 0%
embryo(s) or CL in the treated ewes. Ultrasonography at 21 dpc corresponded with P4
concentrations whereas viable embryos and CL(s) were observed in 100 % of control
group ewes and 0 % embryos or CL(s) for all ewes in the treatment group.
Treatment of ewes with 60 µg/kg BW PG-PS (n=8) increased (p<0.001)
production of TNF-α measured in caudal vena cava via saphenous vein compared to
jugular vein (Figure 2). Additionally, concentration of TNF-α was increased (p=0.02) in
control ewes (n=4) compared to treated ewes (n=4) (Figure 3).
Plasma SAA concentrations increased in all ewes compared to baseline values at
0 hours (Figure 4). SAA concentrations for the treated ewes differed (p<0.0001) from
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those in controls with a biphasic pattern in treated ewes (peaks at 2 hours and at 6 hours)
exhibiting a 5 fold increase compared to baseline values.
Hp concentrations began to increase at 1 hour and continued to increase until 48
hours where a plateau was observed in all treated ewes (Figure 5). There was a
significant difference in haptoglobin concentrations between treated and control ewes
(p<0.0001), with a mean concentration of 1.10 ± 0.20 mg/mL for treated and 0.45 ± 0.10
mg/mL for controls. When compared to baseline concentrations, the treatment group had
a 10 fold increase in Hp concentration, whereas there was no change among control ewes.
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EWE
#
5222
5168
5166
5202
5148
5164
5146
69
549

Group
C
C
C
C
C
C
C
C
C

1
3
99
4287
5225
5151
3149
400
4304
346

TRT
TRT
TRT
TRT
TRT
TRT
TRT
TRT
TRT
TRT

14 dpc

21 dpc

TEMP
0 hr
102.5
101.2
102.2
102.8
102.1
103.1
103.0
101.8
102.0
102.3

TEMP
12 hrs
102.9
101.0
102.6
102.5
102.4
103.0
103.0
102.2
101.9
102.4

TEMP
48 hrs
102.8
101.0
102.8
102.0
101.9
103.1
102.6
102.2
102.0
102.3

vaginal
discharge
no
no
no
no
no
no
no
no
no

progesterone
(ng/ml)
2.12
1.32
3.24
2.08
2.70
2.64
2.40
2.61
2.12
2.14

progesterone
(ng/ml)
2.16
1.40
3.30
2.10
2.44
2.80
2.14
2.30
2.32
2.40

Ultrasound
Results
Pregnant
Pregnant
Pregnant
Pregnant
Pregnant
Pregnant
Pregnant
Pregnant
Pregnant

102.1
101.0
102.2
103.0
102.8
101.8
102.4
102.6
102.0
101.0
102.1

103.9
104.8
103.3
104.4
105.1
105.6
105.0
104.6
105.6
102.9
104.5

102.4
101.8
102.4
102.8
103.0
102.2
102.4
102.8
102.4
101.6
102.4

yes
yes
yes
yes
yes
yes
yes
yes
yes
yes

0.00
2.42
2.08
1.08
2.78
2.42
1.12
0.00
0.00
1.57
1.60

0.86
0.74
0.66
0.66
0.00
1.04
0.00
0.96
1.10
0.32
0.74

Open
Open
Open
Open
Open
Open
Open
Open
Open
Open

Table 1, Plasma Progesterone Concentrations at 14 and 21 dpc in Jugular Blood, Mean
Body Temperatures, Vaginal Discharge and Ultrasonography Results in Suffolk Ewes.
C= control, TRT= treated with 60 µg/kg BW PG-PS
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Figure 2, TNF-α Concentrations Between Sampling Sites; Caudal Vena Cava via
Saphenous Vein and Jugular Blood in Suffolk Ewes. n=8, p<0.001
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Figure 3, Plasma TNF-α Concentrations in Caudal Vena Caval Blood in PG-PS Treated
Suffolk Ewes. n=8, p=0.02
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Figure 4, Plasma Concentrations of Serum Amyloid A in Jugular Blood in Suffolk Ewes.
n=19, p<0.0001
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Figure 5, Plasma Concentrations of Haptoglobin in Jugular Blood in Suffolk Ewes.
n=19, p<0.0001

41

Discussion
Stewart et al. (2003) observed that in addition to increased body temperature and
concentration of plasma cortisol , ewes intoxicated with a medium, 30 µg/kg BW, or high
dose, 60 µg/kg BW PG-PS had an increased pregnancy loss 40 % verses 0 % in control.
In the current experiment a dose of 60 µg/kg BW PG-PS illicited an increase in body
temperature by 2.5 °C higher than in controls, as well as resulted in 100 % embryonic
loss for treated ewes compared to 0 % loss in controls. Rogers (2006) found that a dose
of 30 µg/kg BW, PG-PS was sufficient to elicit an immune response characterized by an
increase in vena cava TNF-α concentrations. At present, a PG-PS dose of 60 µg/kg BW
supported work by Rogers (2006) resulting in a difference in TNF-α concentrations
among sampling sites and in treated compared to control groups. However, in contrast,
TNF-α concentrations were higer in control ewes compared to treated ewes with a dose
of 60 µg/kg BW PG-PS. Possibly, the anesthetic, ketamine, diazapam, and isoflurene
gas, used for the saphenous vein catheter placement surgery affected the response. In the
mouse (Takenaka et al., 1994), the use of Diazapam, Isoflurene or Halothane gas caused
a suppression in endotoxin-induced TNF-α concentrations for up to 36 hours after
administration. Additional work in mice (Shaked et al., 2004) and human beings (Beilin
et al., 2007) showed similar results.
Acute phase proteins, SAA and Hp, are stimulated by IL-6 at the initiation of the
acute phase response, within hours of injury and usually subside within 24 to 48 hours.
Used as biomarkers for infection, acute phase proteins themselves act as important
components of the innate immune system including clotting molecules, protease
inhibitors, and metal-binding proteins (Tizzard, 2004). Both SAA and Hp concentrations
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were observed to be significantly different among treated and controls for this
experiment, with treated ewes experiencing a 5 fold and 3 fold increase from baseline,
respectively. Therefore, with an increase in acute phase proteins it is logical to conclude
that a dose of 60 µg/kg BW, PG-PS illicited an acute phase response of the innate
immune system.
In the current research, all treated ewes had a significant increase in body
temperature, fever, behavioral changes characterisitc of a sick animal, and vaginal
discharge. Fever along with vaginal discharge allows the conclusion that not only did
challenged animals experience a systemic inflammatory response, but also a localized
response in the reproductive tract. In addition, treated ewes experienced 100 %
embryonic loss when compared to controls, with losses occuring between time of PG-PS
intoxication at 5-6 dpc until 14 to 21 dpc when transrectal ultrasound and plasma P4
concentrations were sampled. Although pregnancy loss corresponding with activation of
an acute phase response via bacterial infection has yet to be formally characterized, some
possible mechanism behind such embryonic loss could be:
1. Disruptions in the hypothalamic-pituitary-adrenal axis via disruption in CL
lifespan via increases in PGF2α or increased cortisol concentrations could be a
possibility. A reaction to stress with in an organism is an increase in
production of cortisol by the adrenal cortex. Once in circulation cortisol can
act directly or indirectly in the stimulation of PGF2α in uterine endometrium,
and in the suppression of GnRH production resulting in a decrease in LH and
thus a decrease in P4 which would ultimately result in the death of the CL.
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With the CL being the main producer of P4, the pregnancy maintainance
hormone, at this time in gestation, embryo loss would be eminant.
2. As shown by Hansen et al. (2007), the early embryo, day 2-7 dpc, is
vulnerable to endogenous toxins within the uterine environment. Using TNF-α
Hansen and colleagues showed that embryo during this time of gestation are
susseptible to invasion of such a molecule, across the zona pellucida resulting
in embryonic death. However, as the embryo developes and ages, 8 dpc and
beyond, it becomes more resistant to perturbation and thus is more tolerant.
During the time of PG-PS challenge in our experiment, the embryo, 5-6 dpc,
would be vulnerable and be targeted by proinflammatory cytokines and
immune cells that may identify it as a possible pathogen and destroy it.
3. An early disruption in the uterine environment may not immediately lead to
embryonic loss, or target the embryo specifically, however could cause
problems during implantation or maternal recognition of pregnancy. The
series of events from fertilization to maternal recognition of pregnancy require
complexed coordination amongst a multitude of factors, it is rational to
assume that any disturbance within this system could cause either the embryo
or the uterine envirionment to be unprepared to accept one another. This lack
of tolerance on the maternal side would disallow the embryo to implant,
thereby no recognition of pregnancy would be initiated and ultimately
pregnancy would be terminated.
There is no doubt that the early embro is vulnerable to any disturbances within
the environment in which it lives. An immune response, via bacterial
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infections, would be capable of responding to a conceptus at this time, 5-6
dpc, as a foreign pathogen and destroy it. Moreover, the embro itself may be
able to survive an innate immune challenge, however the uterine environment
itself be damaged due to a localized inflammatory response. Regardless of
indirect or direct actions, bacterial infections, such as mastitis cost the
agricultural industry approximately $2 billion each year (Pyorala, 2002). It is
imparitive that more research is carried out to better understand and
characterize the detrimental effects that such bacterial infections not only have
on the dam, but potentially on the fetus as well. By better understanding
mechanism of actions scientists can work to implement proper management
techniques to not only treat, but prevent bacterial related economic losses that
producers can utilize to their fullest extent.
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